title: Tolvaptan inhibition of desmopressin effects on coagulation factors in a patient with decreased von Willebrand factor and polycystic kidney disease.
authors.forename: Jon D
authors.initials: JD
authors.lastname: Blumenfeld
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Tepler
authors.forename: Andreas
authors.initials: A
authors.lastname: Mauer
authors.forename: Barry
authors.initials: B
authors.lastname: Coller
authors.forename: Daniel G
authors.initials: DG
authors.lastname: Bichet
authors.forename: Barry
authors.initials: B
authors.lastname: Smith
mesh_terms: D000328:Adult; D001552:Benzazepines / Q000494:pharmacology* / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000187:drug effects / Q000378:metabolism*; D003894:Deamino Arginine Vasopressin / Q000037:antagonists & inhibitors*; D015536:Down-Regulation / Q000187:drug effects; D006801:Humans; D008297:Male; D007690:Polycystic Kidney Diseases / Q000097:blood* / Q000188:drug therapy; D000077602:Tolvaptan; D014841:von Willebrand Factor / Q000032:analysis / Q000378:metabolism*
chemical_list: D001552:Benzazepines; D001779:Blood Coagulation Factors; D014841:von Willebrand Factor; D000077602:Tolvaptan; D003894:Deamino Arginine Vasopressin